☰

Some patients with incurable tumors and BRCA mutations respond to new 2-drug combination




Dana-Farber scientists find when given together, two orally available experimental drugs -- sapacitabine and seliciclib -- worked together to elicit antitumor effects in patients with incurable BRCA-deficient cancers.

Fuente : http://www.eurekalert.org/pub_releases/2013-04/dci...

Domingo, 7 de Abril 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección